Pamela McKay

35PUBLICATIONS
219CO-AUTHORS
Haematological tumoursImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Apr 14, 2026
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs

|Sep 08, 2025
CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Lara E Buermann, Louise Stanton, Matthew J J Rose-Zerilli

|Jul 15, 2025
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.

Julia J Scarisbrick, Pietro Quaglino, Sean Whittaker

|May 19, 2025
Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline.

Sridhar Chaganti, Christopher P Fox, Bernard D Maybury

|May 06, 2025
An international real-world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators.

Catherine Tang, Catriona Downie, Mandeep S Sagoo

Pageof 6